Pharmaceutical microbiology is a specialized field within the pharmaceutical industry that focuses on the study of microorganisms and their impact on the production and quality of pharmaceutical products. Microorganisms, such as bacteria, fungi, viruses, and parasites, can pose significant challenges to the manufacturing process and the safety of pharmaceuticals.
One critical aspect of pharmaceutical microbiology is ensuring the sterility of pharmaceutical products, especially injectable medications and other sterile formulations. Microbial limits testing is essential procedure that establishes the acceptable levels of microbial contamination in non-sterile pharmaceuticals.
In addition to quality control measures, pharmaceutical microbiologists play a crucial role in monitoring and maintaining the cleanliness of manufacturing facilities. Environmental monitoring involves regularly testing the air, surfaces, and personnel for microbial contamination to prevent the introduction of harmful microorganisms during the production process.
The field of pharmaceutical microbiology is dynamic, evolving to address emerging challenges such as antimicrobial resistance and the development of microbiome-based therapies. By integrating microbiological principles into pharmaceutical practices, this discipline ensures the production of safe and effective medications for global healthcare.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico